Status:
UNKNOWN
Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches
Lead Sponsor:
University of Zurich
Conditions:
Corona Virus Infection
ARDS
Eligibility:
All Genders
18+ years
Brief Summary
In light of the rapidly emerging pandemic of SARS-CoV-2 infections, the global population and health care systems are facing unprecedented challenges through the combination of transmission and the po...
Detailed Description
In December 2019, severe pneumonia cases were reported in relation to the Huanan Seafood Wholesale Market in Wuhan, China. Four months and more than thousand deaths later, the responsible pathogen of ...
Eligibility Criteria
Inclusion
- Age ≥18 years on day of inclusion
- SARS-CoV-2 infection confirmed according to WHO guidelines
- Hospitalization in intensive care unit for severe ARDS
- Confirmation of an independent doctor to safeguard the interests of the patient
Exclusion
- • Visible opposition to participate in the research project, expressed either verbally or through behavior
Key Trial Info
Start Date :
April 9 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04410263
Start Date
April 9 2020
End Date
December 31 2023
Last Update
June 1 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Zurich
Zurich, Canton of Zurich, Switzerland, 8091